arrow
M

Michael B. Sawyer

Henry Ford Hospital
H指数:56
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study

应对令人痛苦的症状:胰腺酶替代疗法可缓解晚期胰腺癌化疗期间的腹部症状和体重减轻:一项前瞻性研究

2026-02-010
OAAI
New insights into total and resting energy expenditure using state-of-the-art methods in cancer survivors: a cross-sectional study

采用最先进方法对癌症幸存者总能量消耗和静息能量消耗的新见解:一项横断面研究

2025-09-250
PREAI
Nivolumab combination therapies in patients with advanced gastric and gastroesophageal junction cancer: the phase II FRACTION gastric cancer study

Nivolumab联合治疗晚期胃癌和胃食管交界癌患者: II期胃癌研究

2025-02-010
OAAI
Pembrolizumab Plus Binimetinib With or Without Chemotherapy for MSS/pMMR Metastatic Colorectal Cancer: Outcomes From KEYNOTE-651 Cohorts A, C, and E

Pembrolizumab联合Binimetinib联合化疗或不联合化疗治疗MSS/pMMR转移性结直肠癌: 来自651主题的队列A、C和E的结果

2024-06-010
PRE
Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Nivolumab联合低剂量ipilimumab治疗先前治疗的微卫星不稳定性高/错配修复缺陷转移性结直肠癌患者: 来自CheckMate 142的4年随访

2022-10-01117
OA
Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours
2019-10-0127
OAAI